Abiopharma

Cleveland-Cliffs Reports First-Quarter 2026 Results

High Tide Celebrates 4/20 with New Canna Cabana in Caledonia, Ontario

QXO Announces Investor Presentation Regarding Acquisition of TopBuild

Tower Semiconductor Announces First Quarter 2026 Financial Results and Conference Call

Equinor ASA: Notice of annual general meeting 12 May 2026

Philips IR alert | First quarter 2026 results publication

Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease

Omdia：2026年AMOLED智能手机面板出货量预计将大幅下滑

Omdia：2026年AMOLED智慧型手機面板出貨量預計將大幅下滑

WeRide’s WRD 3.0 Makes History as the Only Four‑Time Champion at China Urban Intelligent Driving Competition